Avricore Health (TSE:AVCR) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Avricore Health is expanding its HealthTab point-of-care testing platform through a new agreement with Rexall Pharmacy Group, aiming to deploy the technology in at least 20 more locations in Alberta and Ontario. This expansion is expected to empower pharmacists and patients with quick access to health data for better treatment plans and outcomes. HealthTab’s network is designed to facilitate more active pharmacist roles in primary care and provide patients with immediate test results and health insights.
For further insights into TSE:AVCR stock, check out TipRanks’ Stock Analysis page.
